| Year |
Citation |
Score |
| 2024 |
Cafaro A, Schietroma I, Sernicola L, Belli R, Campagna M, Mancini F, Farcomeni S, Pavone-Cossut MR, Borsetti A, Monini P, Ensoli B. Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis. International Journal of Molecular Sciences. 25. PMID 38338977 DOI: 10.3390/ijms25031704 |
0.466 |
|
| 2022 |
Cafaro A, Ensoli B. HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine. Expert Review of Vaccines. 1-11. PMID 35695268 DOI: 10.1080/14760584.2022.2089119 |
0.348 |
|
| 2021 |
Ensoli B, Moretti S, Borsetti A, Maggiorella MT, Buttò S, Picconi O, Tripiciano A, Sgadari C, Monini P, Cafaro A. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target. Archives of Virology. PMID 34390393 DOI: 10.1007/s00705-021-05158-z |
0.663 |
|
| 2021 |
Tripiciano A, Picconi O, Moretti S, Sgadari C, Cafaro A, Francavilla V, Arancio A, Paniccia G, Campagna M, Pavone-Cossut MR, Sighinolfi L, Latini A, Mercurio VS, Pietro MD, Castelli F, ... ... Ensoli B, et al. Anti-Tat immunity defines CD4 T-cell dynamics in people living with HIV on long-term cART. Ebiomedicine. 66: 103306. PMID 33839064 DOI: 10.1016/j.ebiom.2021.103306 |
0.678 |
|
| 2020 |
Cafaro A, Barillari G, Moretti S, Palladino C, Tripiciano A, Falchi M, Picconi O, Pavone Cossut MR, Campagna M, Arancio A, Sgadari C, Andreini C, Banci L, Monini P, Ensoli B. HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication. International Journal of Molecular Sciences. 22. PMID 33396807 DOI: 10.3390/ijms22010317 |
0.69 |
|
| 2020 |
Qiu Y, Maione F, Capano S, Meda C, Picconi O, Brundu S, Pisacane A, Sapino A, Palladino C, Barillari G, Monini P, Bussolino F, Ensoli B, Sgadari C, Giraudo E. HIV-protease inhibitors block HPV16-induced murine cervical carcinoma and promote vessel normalization in association with MMP-9 inhibition and TIMP-3 induction. Molecular Cancer Therapeutics. PMID 33082275 DOI: 10.1158/1535-7163.MCT-20-0055 |
0.682 |
|
| 2020 |
Maggiorella MT, Sanarico N, Brindicci G, Monno L, Santoro CR, Coppola N, Cuomo N, Azzurri A, Cesario F, Luciani F, El-Hamad I, D'Ettorre G, Turriziani O, Mazzuti L, Poggi A, ... ... Ensoli B, et al. High HIV-1 diversity in immigrants resident in Italy (2008-2017). Scientific Reports. 10: 3226. PMID 32094387 DOI: 10.1038/s41598-020-59084-2 |
0.375 |
|
| 2020 |
Moretti S, Cafaro A, Tripiciano A, Picconi O, Buttò S, Ensoli F, Sgadari C, Monini P, Ensoli B. HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy. Expert Review of Vaccines. 1-14. PMID 31957513 DOI: 10.1080/14760584.2020.1712199 |
0.661 |
|
| 2019 |
Cafaro A, Tripiciano A, Picconi O, Sgadari C, Moretti S, Buttò S, Monini P, Ensoli B. Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease. Vaccines. 7. PMID 31454973 DOI: 10.3390/Vaccines7030099 |
0.694 |
|
| 2019 |
Sgadari C, Monini P, Tripiciano A, Picconi O, Casabianca A, Orlandi C, Moretti S, Francavilla V, Arancio A, Paniccia G, Campagna M, Bellino S, Meschiari M, Nozza S, Sighinolfi L, ... ... Ensoli B, et al. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study. Frontiers in Immunology. 10: 233. PMID 30815001 DOI: 10.3389/Fimmu.2019.00233 |
0.653 |
|
| 2018 |
Barillari G, Monini P, Sgadari C, Ensoli B. The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies. International Journal of Molecular Sciences. 19. PMID 29747434 DOI: 10.3390/Ijms19051418 |
0.643 |
|
| 2018 |
Nicoli F, Gallerani E, Sforza F, Finessi V, Chachage M, Geldmacher C, Cafaro A, Ensoli B, Caputo A, Gavioli R. The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naïve CD4+ T cells. Aids (London, England). 32: 575-581. PMID 29280760 DOI: 10.1097/QAD.0000000000001734 |
0.302 |
|
| 2018 |
Cafaro A, Sgadari C, Picconi O, Tripiciano A, Moretti S, Francavilla V, Pavone Cossut MR, Buttò S, Cozzone G, Ensoli F, Monini P, Ensoli B. "cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies". Expert Review of Vaccines. 17: 115-126. PMID 29243498 DOI: 10.1080/14760584.2018.1418666 |
0.65 |
|
| 2017 |
Bacigalupo I, Palladino C, Leone P, Toschi E, Sgadari C, Ensoli B, Barillari G. Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells. Oncology Letters. 13: 2903-2908. PMID 28521396 DOI: 10.3892/ol.2017.5835 |
0.403 |
|
| 2016 |
Barillari G, Palladino C, Bacigalupo I, Leone P, Falchi M, Ensoli B. Entrance of the Tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels. Oncology Letters. 12: 2389-2394. PMID 27698804 DOI: 10.3892/ol.2016.4921 |
0.309 |
|
| 2016 |
Nicoli F, Chachage M, Clowes P, Bauer A, Kowour D, Ensoli B, Cafaro A, Maboko L, Hoelscher M, Gavioli R, Saathoff E, Geldmacher C. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort. Bmc Infectious Diseases. 16: 344. PMID 27450538 DOI: 10.1186/s12879-016-1647-3 |
0.419 |
|
| 2016 |
Ensoli B, Nchabeleng M, Ensoli F, Tripiciano A, Bellino S, Picconi O, Sgadari C, Longo O, Tavoschi L, Joffe D, Cafaro A, Francavilla V, Moretti S, Pavone Cossut MR, Collacchi B, et al. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial. Retrovirology. 13: 34. PMID 27277839 DOI: 10.1186/S12977-016-0261-1 |
0.674 |
|
| 2016 |
Gray GE, Laher F, Lazarus E, Ensoli B, Corey L. Approaches to preventative and therapeutic HIV vaccines. Current Opinion in Virology. 17: 104-109. PMID 26985884 DOI: 10.1016/J.Coviro.2016.02.010 |
0.346 |
|
| 2016 |
Ensoli B, Cafaro A, Amicosante M, Andrieu JM, Boyer JD, Garcia F, Gray G, King MR, Rios A, Sandstrom E, Regenmortel MHV. Old and New Concepts and Strategies in HIV Vaccinology: A Report from a Workshop held in Rome on 17 June 2016 Journal of Aids & Clinical Research. 7. DOI: 10.4172/2155-6113.1000634 |
0.328 |
|
| 2015 |
Sanarico N, D'Amato S, Picconi O, Ensoli B, Buttò S. Building up a collaborative network for the surveillance of HIV genetic diversity in Italy. A pilot study. Annali Dell'Istituto Superiore Di Sanita. 51: 321-6. PMID 26783219 DOI: 10.4415/ANN_15_04_12 |
0.358 |
|
| 2015 |
Cafaro A, Tripiciano A, Sgadari C, Bellino S, Picconi O, Longo O, Francavilla V, Buttò S, Titti F, Monini P, Ensoli F, Ensoli B. Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine. Expert Opinion On Biological Therapy. 15: S13-29. PMID 26096836 DOI: 10.1517/14712598.2015.1021328 |
0.689 |
|
| 2015 |
Ensoli F, Cafaro A, Casabianca A, Tripiciano A, Bellino S, Longo O, Francavilla V, Picconi O, Sgadari C, Moretti S, Cossut MR, Arancio A, Orlandi C, Sernicola L, Maggiorella MT, ... ... Ensoli B, et al. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial. Retrovirology. 12: 33. PMID 25924841 DOI: 10.1186/S12977-015-0151-Y |
0.666 |
|
| 2014 |
Titti F, Maggiorella MT, Ferrantelli F, Sernicola L, Bellino S, Collacchi B, Fanales Belasio E, Moretti S, Pavone Cossut MR, Belli R, Olivieri E, Farcomeni S, Compagnoni D, Michelini Z, Sabbatucci M, ... ... Ensoli B, et al. Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines. Plos One. 9: e111360. PMID 25356594 DOI: 10.1371/journal.pone.0111360 |
0.351 |
|
| 2014 |
Chiozzini C, Collacchi B, Nappi F, Bauer T, Arenaccio C, Tripiciano A, Longo O, Ensoli F, Cafaro A, Ensoli B, Federico M. Surface-bound Tat inhibits antigen-specific CD8+ T-cell activation in an integrin-dependent manner. Aids (London, England). 28: 2189-200. PMID 25313583 DOI: 10.1097/QAD.0000000000000389 |
0.376 |
|
| 2014 |
Ensoli B, Cafaro A, Monini P, Marcotullio S, Ensoli F. Challenges in HIV Vaccine Research for Treatment and Prevention. Frontiers in Immunology. 5: 417. PMID 25250026 DOI: 10.3389/Fimmu.2014.00417 |
0.685 |
|
| 2014 |
Sicurella M, Nicoli F, Gallerani E, Volpi I, Berto E, Finessi V, Destro F, Manservigi R, Cafaro A, Ensoli B, Caputo A, Gavioli R, Marconi PC. An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge. Plos One. 9: e100844. PMID 25033084 DOI: 10.1371/journal.pone.0100844 |
0.343 |
|
| 2014 |
Bellino S, Tripiciano A, Picconi O, Francavilla V, Longo O, Sgadari C, Paniccia G, Arancio A, Angarano G, Ladisa N, Lazzarin A, Tambussi G, Nozza S, Torti C, Focà E, ... ... Ensoli B, et al. The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study. Retrovirology. 11: 49. PMID 24961156 DOI: 10.1186/1742-4690-11-49 |
0.676 |
|
| 2014 |
Sforza F, Nicoli F, Gallerani E, Finessi V, Reali E, Cafaro A, Caputo A, Ensoli B, Gavioli R. HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors. Aids (London, England). 28: 1729-38. PMID 24841128 DOI: 10.1097/QAD.0000000000000315 |
0.338 |
|
| 2014 |
Cenci A, D'Avenio G, Tavoschi L, Chiappi M, Becattini S, Narino Mdel P, Picconi O, Bernasconi D, Fanales-Belasio E, Vardas E, Sukati H, Lo Presti A, Ciccozzi M, Monini P, Ensoli B, et al. Molecular characterization of HIV-1 subtype C gp-120 regions potentially involved in virus adaptive mechanisms. Plos One. 9: e95183. PMID 24788065 DOI: 10.1371/Journal.Pone.0095183 |
0.628 |
|
| 2014 |
Barillari G, Iovane A, Bacigalupo I, Labbaye C, Chiozzini C, Sernicola L, Quaranta MT, Falchi M, Sgadari C, Ensoli B. The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells. Angiogenesis. 17: 831-8. PMID 24719186 DOI: 10.1007/s10456-014-9430-9 |
0.342 |
|
| 2013 |
Nicoli F, Finessi V, Sicurella M, Rizzotto L, Gallerani E, Destro F, Cafaro A, Marconi P, Caputo A, Ensoli B, Gavioli R. The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. Plos One. 8: e77746. PMID 24223723 DOI: 10.1371/journal.pone.0077746 |
0.363 |
|
| 2013 |
Cortecchia S, Galanti G, Sgadari C, Costa S, De Lillo M, Caprara L, Barillari G, Monini P, Nannini R, Ensoli B, Bucchi L. Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16Ink4a. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 23: 1663-9. PMID 24172101 DOI: 10.1097/Igc.0B013E3182A80B14 |
0.524 |
|
| 2012 |
Monini P, Cafaro A, Srivastava IK, Moretti S, Sharma VA, Andreini C, Chiozzini C, Ferrantelli F, Cossut MR, Tripiciano A, Nappi F, Longo O, Bellino S, Picconi O, Fanales-Belasio E, ... ... Ensoli B, et al. HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies. Plos One. 7: e48781. PMID 23152803 DOI: 10.1371/Journal.Pone.0048781 |
0.694 |
|
| 2012 |
Cenci JA, Tavoschi L, D'Avenio G, Narino P, Becattini S, Bernasconi D, Chiappi M, Torre Ll, Sukati H, Vardas E, Presti Al, Cella E, Ciccozzi M, Picconi O, Monini P, ... Ensoli B, et al. Characterization of variable regions of the Gp120 protein from HIV-1 subtype C virus variants obtained from individuals at different disease stages in Sub-Saharan Africa Journal of Aids and Clinical Research. PMID 22866240 DOI: 10.4172/2155-6113.S1.004 |
0.665 |
|
| 2012 |
Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Armignacco O, Carosi G, Cinque P, d'Arminio Monforte A, Di Perri G, Ensoli B, Floridia M, Galli M, Mastroianni C, Matteelli A, et al. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011. The New Microbiologica. 35: 113-59. PMID 22707127 |
0.33 |
|
| 2012 |
Barillari G, Iovane A, Bacigalupo I, Palladino C, Bellino S, Leone P, Monini P, Ensoli B. Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity Aids. 26: 909-919. PMID 22313963 DOI: 10.1097/Qad.0B013E328351F7A5 |
0.678 |
|
| 2012 |
Malnati MS, Heltai S, Cosma A, Reitmeir P, Allgayer S, Glashoff RH, Liebrich W, Vardas E, Imami N, Westrop S, Nozza S, Tambussi G, Buttò S, Fanales-Belasio E, Ensoli B, et al. A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses. Journal of Immunological Methods. 375: 46-56. PMID 21963950 DOI: 10.1016/j.jim.2011.09.005 |
0.363 |
|
| 2011 |
Sgadari C, Barillari G, Palladino C, Bellino S, Taddeo B, Toschi E, Ensoli B. Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma. International Journal of Vascular Medicine. 2011: 452729. PMID 22007303 DOI: 10.1155/2011/452729 |
0.428 |
|
| 2011 |
Antinori A, Marcotullio S, Ammassari A, Andreoni M, Angarano G, Carosi G, Cinque P, d'Arminio Monforte A, Di Perri G, Ensoli B, Ferrazzi E, Galli M, Mastroianni C, Matteelli A, Mazzotta F, et al. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. The New Microbiologica. 34: 109-46. PMID 21617825 |
0.33 |
|
| 2011 |
Toschi E, Sgadari C, Malavasi L, Bacigalupo I, Chiozzini C, Carlei D, Compagnoni D, Bellino S, Bugarini R, Falchi M, Palladino C, Leone P, Barillari G, Monini P, Ensoli B. Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases International Journal of Cancer. 128: 82-93. PMID 20617515 DOI: 10.1002/Ijc.25550 |
0.65 |
|
| 2011 |
Sgadari C, Barillari G, Palladino C, Bellino S, Taddeo B, Toschi E, Ensoli B. Fibroblast growth factor-2 and the HIV-1 Tat protein synergize in promoting BCL-2 expression and preventing endothelial cell apoptosis: Implications for the pathogenesis of AIDS-associated kaposi's sarcoma International Journal of Vascular Medicine. 2011. DOI: 10.1155/2011/452729 |
0.424 |
|
| 2010 |
Ensoli B, Bellino S, Tripiciano A, Longo O, Francavilla V, Marcotullio S, Cafaro A, Picconi O, Paniccia G, Scoglio A, Arancio A, Ariola C, Ruiz Alvarez MJ, Campagna M, Scaramuzzi D, et al. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART. Plos One. 5: e13540. PMID 21085635 DOI: 10.1371/journal.pone.0013540 |
0.31 |
|
| 2010 |
Pierleoni R, Menotta M, Antonelli A, Sfara C, Serafini G, Dominici S, Laguardia ME, Salis A, Damonte G, Banci L, Porcu M, Monini P, Ensoli B, Magnani M. Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking. Molecular and Cellular Biochemistry. 345: 105-18. PMID 20721684 DOI: 10.1007/S11010-010-0564-9 |
0.593 |
|
| 2010 |
Cafaro A, Bellino S, Titti F, Maggiorella MT, Sernicola L, Wiseman RW, Venzon D, Karl JA, O'Connor D, Monini P, Robert-Guroff M, Ensoli B. Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P. Journal of Virology. 84: 8953-8. PMID 20554774 DOI: 10.1128/Jvi.00377-10 |
0.585 |
|
| 2010 |
Bernasconi D, Tavoschi L, Regine V, Raimondo M, Gama D, Sulgencio L, Almaviva M, Galli C, Ensoli B, Suligoi B, Sukati H, Buttò S. Identification of recent HIV infections and of factors associated with virus acquisition among pregnant women in 2004 and 2006 in Swaziland. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 48: 180-3. PMID 20537582 DOI: 10.1016/j.jcv.2010.04.010 |
0.404 |
|
| 2010 |
Barillari G, Franzese O, Comandini A, Bonmassar E, Ensoli B. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors. Oncology Reports. 24: 219-23. PMID 20514465 DOI: 10.3892/or-00000849 |
0.332 |
|
| 2010 |
Papathanasopoulos MA, Vardas E, Wallis C, Glashoff R, Buttó S, Poli G, Malnati M, Clerici M, Ensoli B. Characterization of HIV type 1 genetic diversity among South African participants enrolled in the AIDS Vaccine Integrated Project (AVIP) study. Aids Research and Human Retroviruses. 26: 705-9. PMID 20509797 DOI: 10.1089/aid.2009.0281 |
0.38 |
|
| 2009 |
Cafaro A, Macchia I, Maggiorella MT, Titti F, Ensoli B. Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS. Advances in Experimental Medicine and Biology. 655: 189-242. PMID 20047043 DOI: 10.1007/978-1-4419-1132-2_14 |
0.418 |
|
| 2009 |
Bellino S, Francavilla V, Longo O, Tripiciano A, Paniccia G, Arancio A, Fiorelli V, Scoglio A, Collacchi B, Campagna M, Lazzarin A, Tambussi G, Din CT, Visintini R, Narciso P, ... ... Ensoli B, et al. Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate. Reviews On Recent Clinical Trials. 4: 195-204. PMID 20028332 DOI: 10.2174/157488709789957529 |
0.642 |
|
| 2009 |
Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, Di Carlo A, Tripiciano A, Longo O, Bellino S, Francavilla V, Paniccia G, Arancio A, Scoglio A, Collacchi B, et al. The preventive phase I trial with the HIV-1 Tat-based vaccine. Vaccine. 28: 371-8. PMID 19879233 DOI: 10.1016/J.Vaccine.2009.10.038 |
0.671 |
|
| 2009 |
Caputo A, Gavioli R, Bellino S, Longo O, Tripiciano A, Francavilla V, Sgadari C, Paniccia G, Titti F, Cafaro A, Ferrantelli F, Monini P, Ensoli F, Ensoli B. HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development. International Reviews of Immunology. 28: 285-334. PMID 19811313 DOI: 10.1080/08830180903013026 |
0.672 |
|
| 2009 |
Nappi F, Chiozzini C, Bordignon V, Borsetti A, Bellino S, Cippitelli M, Barillari G, Caputo A, Tyagi M, Giacca M, Ensoli B. Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles. The Journal of Gene Medicine. 11: 955-65. PMID 19653251 DOI: 10.1002/Jgm.1381 |
0.339 |
|
| 2009 |
Fanales-Belasio E, Moretti S, Fiorelli V, Tripiciano A, Pavone Cossut MR, Scoglio A, Collacchi B, Nappi F, Macchia I, Bellino S, Francavilla V, Caputo A, Barillari G, Magnani M, Laguardia ME, ... ... Ensoli B, et al. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 2888-97. PMID 19234184 DOI: 10.4049/Jimmunol.0711406 |
0.643 |
|
| 2009 |
Longo O, Tripiciano A, Fiorelli V, Bellino S, Scoglio A, Collacchi B, Alvarez MJ, Francavilla V, Arancio A, Paniccia G, Lazzarin A, Tambussi G, Din CT, Visintini R, Narciso P, ... ... Ensoli B, et al. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine. 27: 3306-12. PMID 19208456 DOI: 10.1016/J.Vaccine.2009.01.090 |
0.661 |
|
| 2009 |
Monini P, Sgadari C, Grosso MG, Bellino S, Di Biagio A, Toschi E, Bacigalupo I, Sabbatucci M, Cencioni G, Salvi E, Leone P, Ensoli B. Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir. Aids (London, England). 23: 534-8. PMID 19169139 DOI: 10.1097/Qad.0B013E3283262A8D |
0.678 |
|
| 2009 |
Tinari A, Superti F, Ammendolia MG, Chiozzini C, Hohenadl C, Leone P, Nappi F, Nicoletti M, Borsetti A, Marchetti M, Ensoli B, Monini P. Primary effusion lymphoma cells undergoing human herpesvirus type 8 productive infection produce C-type retroviral particles. International Journal of Immunopathology and Pharmacology. 21: 999-1006. PMID 19144286 DOI: 10.1177/039463200802100425 |
0.576 |
|
| 2008 |
Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, Di Carlo A, Monini P, Magnani M, Garaci E. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein. Aids (London, England). 22: 2207-9. PMID 18832884 DOI: 10.1097/Qad.0B013E32831392D4 |
0.672 |
|
| 2008 |
Caputo A, Brocca-Cofano E, Castaldello A, Voltan R, Gavioli R, Srivastava IK, Barnett SW, Cafaro A, Ensoli B. Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin. Vaccine. 26: 1214-27. PMID 18243435 DOI: 10.1016/j.vaccine.2007.12.030 |
0.416 |
|
| 2008 |
Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, Orsatti R, Ilari R, Sernicola L, Stellacci E, Ensoli B, Battistini A. IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. Journal of Virology. 82: 3632-41. PMID 18216101 DOI: 10.1128/JVI.00599-07 |
0.376 |
|
| 2008 |
Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, Fortini C, Cofano EB, Triulzi C, Cafaro A, Srivastava I, Barnett S, Caputo A, Ensoli B. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS Vaccine. 26: 727-737. PMID 18096278 DOI: 10.1016/j.vaccine.2007.11.040 |
0.331 |
|
| 2008 |
Sgarbanti M, Remoli AL, Marsili G, Perrotti E, Orsatti R, Ilari R, Stellacci E, Ridolfi B, Borsetti A, Sernicola L, Ensoli B, Battistini A. 190 IRF-1 is required for full NF-κB transcriptional activity at the HIV-1 LTR enhancer Cytokine. 43: 284. DOI: 10.1016/J.CYTO.2008.07.252 |
0.302 |
|
| 2007 |
Bråve A, Hinkula J, Cafaro A, Eriksson LE, Srivastava IK, Magnani M, Ensoli B, Barnett SW, Wahren B, Rollman E. Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge Vaccine. 25: 6882-6890. PMID 17707956 DOI: 10.1016/j.vaccine.2007.07.012 |
0.39 |
|
| 2007 |
Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Pavone-Cossut MR, Macchia I, Farcomeni S, Tenner-Racz K, Racz P, Ensoli B, Titti F. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection. Journal of Medical Primatology. 36: 180-94. PMID 17669207 DOI: 10.1111/j.1600-0684.2007.00236.x |
0.345 |
|
| 2007 |
Sirianni MC, Campagna M, Scaramuzzi D, Carbonari M, Toschi E, Bacigalupo I, Monini P, Ensoli B. Control of human herpes virus type 8-associated diseases by NK cells. Annals of the New York Academy of Sciences. 1096: 37-43. PMID 17405914 DOI: 10.1196/Annals.1397.068 |
0.668 |
|
| 2007 |
Titti F, Cafaro A, Ferrantelli F, Tripiciano A, Moretti S, Caputo A, Gavioli R, Ensoli F, Robert-Guroff M, Barnett S, Ensoli B. Problems and emerging approaches in HIV/AIDS vaccine development. Expert Opinion On Emerging Drugs. 12: 23-48. PMID 17355212 DOI: 10.1517/14728214.12.1.23 |
0.416 |
|
| 2007 |
Demberg T, Florese RH, Heath MJ, Larsen K, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, Venzon D, Grant R, Patterson LJ, Korioth-Schmitz B, Buzby A, Dombagoda D, Montefiori DC, ... ... Ensoli B, et al. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques. Journal of Virology. 81: 3414-27. PMID 17229693 DOI: 10.1128/JVI.02453-06 |
0.371 |
|
| 2007 |
Biberfeld P, Ensoli B, Stürzl M, Schulz TF. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma. Current Opinion in Infectious Diseases. 11: 97-105. PMID 17033372 DOI: 10.1097/00001432-199804000-00002 |
0.384 |
|
| 2006 |
Monini P, Toschi E, Sgadari C, Bacigalupo I, Palladino C, Carlei D, Barillari G, Ensoli B. The use of HAART for biological tumour therapy Journal of Hiv Therapy. 11: 53-56. PMID 17580499 |
0.519 |
|
| 2006 |
Ensoli B, Fiorelli V, Ensoli F, Cafaro A, Titti F, Buttò S, Monini P, Magnani M, Caputo A, Garaci E. Candidate HIV-1 Tat vaccine development: from basic science to clinical trials. Aids (London, England). 20: 2245-61. PMID 17117011 DOI: 10.1097/Qad.0B013E3280112Cd1 |
0.683 |
|
| 2006 |
Ferrantelli F, Buttò S, Cafaro A, Wahren B, Ensoli B. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience. Springer Seminars in Immunopathology. 28: 289-301. PMID 16983452 DOI: 10.1007/s00281-006-0026-3 |
0.346 |
|
| 2006 |
Bozac A, Berto E, Vasquez F, Grandi P, Caputo A, Manservigi R, Ensoli B, Marconi P. Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses. Vaccine. 24: 7148-58. PMID 16884834 DOI: 10.1016/J.Vaccine.2006.06.061 |
0.325 |
|
| 2006 |
Buffa V, Negri DRM, Leone P, Bona R, Borghi M, Bacigalupo I, Carlei D, Sgadari C, Ensoli B, Cara A. A single administration of lentiviral vectors expressing either full-length human immunodeficiency virus 1 (HIV-1)(HXB2) Rev/Env or codon-optimized HIV-1(JR-FL) gp120 generates durable immune responses in mice. The Journal of General Virology. 87: 1625-1634. PMID 16690927 DOI: 10.1099/vir.0.81706-0 |
0.33 |
|
| 2006 |
Simonelli C, Talamini R, Bearz A, Berretta M, Spazzapan S, Monini P, Sgadari C, Sartor I, Ensoli B, Tirelli U. Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma Annals of Oncology. 17: 1335-1336. PMID 16569648 DOI: 10.1093/Annonc/Mdl043 |
0.517 |
|
| 2006 |
Remoli AL, Marsili G, Perrotti E, Gallerani E, Ilari R, Nappi F, Cafaro A, Ensoli B, Gavioli R, Battistini A. Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1. The Biochemical Journal. 396: 371-80. PMID 16512786 DOI: 10.1042/BJ20051570 |
0.32 |
|
| 2006 |
Borsutzky S, Ebensen T, Link C, Becker PD, Fiorelli V, Cafaro A, Ensoli B, Guzmán CA. Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant. Vaccine. 24: 2049-56. PMID 16406225 DOI: 10.1016/j.vaccine.2005.11.025 |
0.336 |
|
| 2006 |
Bearz A, Simonelli C, Talamini R, Sgadari C, Monini P, Ensoli B, Spazzapan S, Vaccher E, Berretta M, Tirelli U. Cytokines modulation and activity in non-small cell lung cancer (NSCLC) by chemotherapy and indinavir Journal of Clinical Oncology. 24: 17094-17094. DOI: 10.1200/Jco.2006.24.18_Suppl.17094 |
0.513 |
|
| 2006 |
Simonelli C, Talamini R, Bearz A, Berretta M, Monini P, Sgadari C, Sartor I, Ensoli B, Vaccher E, Tirelli U. Evaluation of angiogenis activation during interleukin-2 infusion in patients with renal cell cancer (RCC) Journal of Clinical Oncology. 24: 14640-14640. DOI: 10.1200/Jco.2006.24.18_Suppl.14640 |
0.517 |
|
| 2005 |
Ensoli B, Cafaro A, Caputo A, Fiorelli V, Ensoli F, Gavioli R, Ferrantelli F, Cara A, Titti F, Magnani M. Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 Env. Microbes and Infection. 7: 1392-9. PMID 16243561 DOI: 10.1016/j.micinf.2005.07.016 |
0.353 |
|
| 2005 |
Zhao J, Voltan R, Peng B, Davis-Warren A, Kalyanaraman VS, Alvord WG, Aldrich K, Bernasconi D, Buttò S, Cafaro A, Ensoli B, Robert-Guroff M. Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. Virology. 342: 1-12. PMID 16109434 DOI: 10.1016/j.virol.2005.07.016 |
0.362 |
|
| 2005 |
Sirianni MC, Libi F, Campagna M, Rossi D, Capello D, Sciaranghella G, Carbone A, Simonelli C, Monini P, Gaidano G, Ensoli B. Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development. British Journal of Haematology. 130: 92-5. PMID 16044583 DOI: 10.1111/J.1365-2141.2005.05581.X |
0.603 |
|
| 2005 |
Rezza G, Fiorelli V, Dorrucci M, Ciccozzi M, Tripiciano A, Scoglio A, Collacchi B, Ruiz-Alvarez M, Giannetto C, Caputo A, Tomasoni L, Castelli F, Sciandra M, Sinicco A, Ensoli F, ... ... Ensoli B, et al. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. The Journal of Infectious Diseases. 191: 1321-4. PMID 15776379 DOI: 10.1086/428909 |
0.386 |
|
| 2005 |
Sirianni MC, Libi F, Campagna M, Rossi D, Capello D, Sciaranghella G, Carbone A, Simonelli C, Monini P, Gaidano G, Ensoli B. Erratum: Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development (British Journal of Haematology (2005) 130, (92-95)) British Journal of Haematology. 131. DOI: 10.1111/J.1365-2141.2005.05748.X |
0.555 |
|
| 2005 |
Bearz A, Simonelli C, Ensoli B, Sgadari C, Monini P, Vaccher E, Spazzapan S, Berretta M, Toffoli G, Tirelli U. P-451 HIV-protease inhibitors as antitumoral therapy in advanced NSCLC patients Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80944-4 |
0.63 |
|
| 2004 |
Sgarbanti M, Marsili G, Remoli AL, Ridolfi B, Stellacci E, Borsetti A, Ensoli B, Battistini A. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation. Annals of the New York Academy of Sciences. 1030: 187-95. PMID 15659797 DOI: 10.1196/annals.1329.024 |
0.384 |
|
| 2004 |
Ferrantelli F, Cafaro A, Ensoli B. Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines. Current Opinion in Biotechnology. 15: 543-56. PMID 15560981 DOI: 10.1016/j.copbio.2004.10.008 |
0.317 |
|
| 2004 |
Caputo A, Gavioli R, Ensoli B. Recent advances in the development of HIV-1 Tat-based vaccines. Current Hiv Research. 2: 357-76. PMID 15544457 DOI: 10.2174/1570162043350986 |
0.382 |
|
| 2004 |
Monini P, Sgadari C, Toschi E, Barillari G, Ensoli B. Antitumour effects of antiretroviral therapy. Nature Reviews. Cancer. 4: 861-75. PMID 15516959 DOI: 10.1038/Nrc1479 |
0.703 |
|
| 2004 |
Gavioli R, Gallerani E, Fortini C, Fabris M, Bottoni A, Canella A, Bonaccorsi A, Marastoni M, Micheletti F, Cafaro A, Rimessi P, Caputo A, Ensoli B. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. Journal of Immunology (Baltimore, Md. : 1950). 173: 3838-43. PMID 15356131 DOI: 10.4049/jimmunol.173.6.3838 |
0.406 |
|
| 2004 |
Negri DR, Buffa V, Leone P, Bona R, Borghi M, Carlini F, De Angelis F, Indraccolo S, Ensoli B, Cara A. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. Journal of Immunological Methods. 291: 153-63. PMID 15345313 DOI: 10.1016/j.jim.2004.05.007 |
0.345 |
|
| 2004 |
Maggiorella MT, Baroncelli S, Michelini Z, Fanales-Belasio E, Moretti S, Sernicola L, Cara A, Negri DR, Buttò S, Fiorelli V, Tripiciano A, Scoglio A, Caputo A, Borsetti A, Ridolfi B, ... ... Ensoli B, et al. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys. Vaccine. 22: 3258-69. PMID 15308348 DOI: 10.1016/j.vaccine.2004.03.009 |
0.317 |
|
| 2004 |
Ridolfi B, Titti F, Fulgenzi D, Maggiorella MT, Tinari A, Superti F, Parolin C, Ensoli B, Borsetti A. Infection of a simian B cell line by human and simian immunodeficiency viruses. Aids Research and Human Retroviruses. 20: 723-32. PMID 15307918 DOI: 10.1089/0889222041524652 |
0.386 |
|
| 2004 |
Franzese O, Comandini A, Adamo R, Sgadari C, Ensoli B, Bonmassar E. HIV-Tat down-regulates telomerase activity in the nucleus of human CD4+ T cells. Cell Death and Differentiation. 11: 782-4. PMID 15017382 DOI: 10.1038/sj.cdd.4401346 |
0.333 |
|
| 2004 |
Dominici S, Laguardia ME, Serafini G, Chiarantini L, Fortini C, Tripiciano A, Brocca-Cofano E, Scoglio A, Caputo A, Fiorelli V, Gavioli R, Cafaro A, Ensoli B, Magnani M. Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. Vaccine. 21: 2073-81. PMID 12706697 DOI: 10.1016/S0264-410X(02)00746-6 |
0.373 |
|
| 2004 |
Simonelli C, Vaccher E, Martellotta F, Tedeschi R, Salvi E, Sgadari C, Monini P, Ensoli B, Tirelli U. Assessment of safety and feasibility of HIV protease inhibitors (PI) as antiangiogenic agents in the treatment of advanced nasopharyngeal carcinoma (NPC) Journal of Clinical Oncology. 22: 3121-3121. DOI: 10.1200/Jco.2004.22.90140.3121 |
0.575 |
|
| 2003 |
Marsili G, Borsetti A, Sgarbanti M, Remoli AL, Ridolfi B, Stellacci E, Ensoli B, Battistini A. On the role of interferon regulatory factors in HIV-1 replication. Annals of the New York Academy of Sciences. 1010: 29-42. PMID 15033691 DOI: 10.1196/annals.1299.005 |
0.328 |
|
| 2003 |
Alessandri G, Fiorentini S, Licenziati S, Bonafede M, Monini P, Ensoli B, Caruso A. CD8(+)CD28(-) T lymphocytes from HIV-1-infected patients secrete factors that induce endothelial cell proliferation and acquisition of Kaposi's sarcoma cell features. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 23: 523-31. PMID 14565861 DOI: 10.1089/10799900360708641 |
0.654 |
|
| 2003 |
Buttò S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, Ciccozzi M, Collacchi B, Sabbatucci M, Cafaro A, Guzmán CA, Borsetti A, Caputo A, Vardas E, Colvin M, ... ... Ensoli B, et al. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. The Journal of Infectious Diseases. 188: 1171-80. PMID 14551888 DOI: 10.1086/378412 |
0.418 |
|
| 2003 |
Sgadari C, Monini P, Barillari G, Ensoli B. Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth. The Lancet. Oncology. 4: 537-47. PMID 12965274 DOI: 10.1016/S1470-2045(03)01192-6 |
0.684 |
|
| 2003 |
Barillari G, Sgadari C, Toschi E, Monini P, Ensoli B. HIV protease inhibitors as new treatment options for Kaposi's sarcoma. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 6: 173-81. PMID 12962683 DOI: 10.1016/S1368-7646(03)00060-8 |
0.682 |
|
| 2003 |
Marinaro M, Riccomi A, Rappuoli R, Pizza M, Fiorelli V, Tripiciano A, Cafaro A, Ensoli B, De Magistris MT. Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA. Vaccine. 21: 3972-81. PMID 12922133 DOI: 10.1016/s0264-410x(03)00295-0 |
0.308 |
|
| 2003 |
Grosso G, Sgadari C, Barillari G, Toschi E, Bacigalupo I, Carlei D, Palladino C, Baccarini S, Malavasi L, Moracci G, Leone P, Chiozzini C, Monini P, Ensoli B. HIV protease inhibitors for the treatment of Kaposi's sarcoma Recenti Progressi in Medicina. 94: 69-74. PMID 12908373 |
0.677 |
|
| 2003 |
Borsutzky S, Fiorelli V, Ebensen T, Tripiciano A, Rharbaoui F, Scoglio A, Link C, Nappi F, Morr M, Buttó S, Cafaro A, Mühlradt PF, Ensoli B, Guzmán CA. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. European Journal of Immunology. 33: 1548-56. PMID 12778472 DOI: 10.1002/eji.200323954 |
0.421 |
|
| 2003 |
Monini P, Sgadari C, Barillari G, Ensoli B. HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity. The Journal of Antimicrobial Chemotherapy. 51: 207-11. PMID 12562682 DOI: 10.1093/Jac/Dkg086 |
0.617 |
|
| 2003 |
Caputo A, Gavioli R, Altavilla G, Brocca-Cofano E, Boarini C, Betti M, Castaldello A, Lorenzini F, Micheletti F, Cafaro A, Sparnacci K, Laus M, Tondelli L, Ensoli B. Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat. Vaccine. 21: 1103-11. PMID 12559787 DOI: 10.1016/s0264-410x(02)00555-8 |
0.321 |
|
| 2003 |
Savarino A, Bensi T, Chiocchetti A, Bottarel F, Mesturini R, Ferrero E, Calosso L, Deaglio S, Ortolan E, Buttò S, Cafaro A, Katada T, Ensoli B, Malavasi F, Dianzani U. Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp120. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 461-3. PMID 12551845 DOI: 10.1096/fj.02-0512fje |
0.325 |
|
| 2002 |
Toschi E, Sgadari C, Monini P, Barillari G, Bacigalupo I, Palladino C, Baccarini S, Carlei D, Grosso G, Sirianni MC, Ensoli B. Treatment of Kaposi's sarcoma - An update Anti-Cancer Drugs. 13: 977-987. PMID 12439331 DOI: 10.1097/00001813-200211000-00001 |
0.658 |
|
| 2002 |
Fanales-Belasio E, Cafaro A, Cara A, Negri DR, Fiorelli V, Butto S, Moretti S, Maggiorella MT, Baroncelli S, Michelini Z, Tripiciano A, Sernicola L, Scoglio A, Borsetti A, Ridolfi B, ... ... Ensoli B, et al. HIV-1 Tat-based vaccines: from basic science to clinical trials. Dna and Cell Biology. 21: 599-610. PMID 12396602 DOI: 10.1089/104454902760330138 |
0.406 |
|
| 2002 |
Sirianni MC, Vincenzi L, Topino S, Giovannetti A, Mazzetta F, Libi F, Scaramuzzi D, Andreoni M, Pinter E, Baccarini S, Rezza G, Monini P, Ensoli B. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. European Journal of Immunology. 32: 2711-20. PMID 12355422 DOI: 10.1002/1521-4141(2002010)32:10<2711::Aid-Immu2711>3.0.Co;2-3 |
0.663 |
|
| 2002 |
Micheletti F, Monini P, Fortini C, Rimessi P, Bazzaro M, Andreoni M, Giuliani M, Traniello S, Ensoli B, Gavioli R. Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology. 106: 395-403. PMID 12100728 DOI: 10.1046/J.1365-2567.2002.01424.X |
0.579 |
|
| 2002 |
Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, Marsili G, Marziali G, Coccia EM, Ensoli B, Battistini A. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. The Journal of Experimental Medicine. 195: 1359-70. PMID 12021315 DOI: 10.1084/jem.20010753 |
0.377 |
|
| 2002 |
Barillari G, Ensoli B. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clinical Microbiology Reviews. 15: 310-26. PMID 11932235 DOI: 10.1128/CMR.15.2.310-326.2002 |
0.448 |
|
| 2002 |
Ensoli B, Cafaro A. HIV-1 Tat vaccines. Virus Research. 82: 91-101. PMID 11885958 DOI: 10.1016/S0168-1702(01)00393-8 |
0.332 |
|
| 2002 |
Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, ... ... Ensoli B, et al. HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma Nature Medicine. 8: 225-232. PMID 11875492 DOI: 10.1038/Nm0302-225 |
0.661 |
|
| 2002 |
Battistini A, Marsili G, Sgarbanti M, Ensoli B, Hiscott J. IRF regulation of HIV-1 long terminal repeat activity. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 22: 27-37. PMID 11846973 DOI: 10.1089/107999002753452638 |
0.304 |
|
| 2002 |
Fanales-Belasio E, Moretti S, Nappi F, Barillari G, Micheletti F, Cafaro A, Ensoli B. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. Journal of Immunology (Baltimore, Md. : 1950). 168: 197-206. PMID 11751963 DOI: 10.4049/jimmunol.168.1.197 |
0.3 |
|
| 2002 |
Ensoli B. HIV protease inhibitors have specific anti-cancer effects Biomedicine & Pharmacotherapy. 56: 424. DOI: 10.1016/S0753-3322(02)00269-X |
0.328 |
|
| 2001 |
Serraino D, Toma L, Andreoni M, Buttò S, Tchangmena O, Sarmati L, Monini P, Franceschi S, Ensoli B, Rezza G. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area European Journal of Epidemiology. 17: 871-876. PMID 12081107 DOI: 10.1023/A:1015678312153 |
0.596 |
|
| 2001 |
Andreoni M, Goletti D, Pezzotti P, Pozzetto A, Monini P, Sarmati L, Farchi F, Tisone G, Piazza A, Pisani F, Angelico M, Leone P, Citterio F, Ensoli B, Rezza G. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. Journal of Infection. 43: 195-199. PMID 11798259 DOI: 10.1053/Jinf.2001.0899 |
0.514 |
|
| 2001 |
Rezza G, Danaya RT, Wagner TM, Sarmati L, Owen IL, Monini P, Andreoni M, Suligoi B, Ensoli B, Pozio E. Human herpesvirus-8 and other viral infections, Papua New Guinea. Emerging Infectious Diseases. 7: 893-5. PMID 11747707 DOI: 10.3201/Eid0705.017522 |
0.587 |
|
| 2001 |
Monini P, Sirianni MC, Franco M, Vincenzi L, Topino S, Goletti D, Leone P, Leone P, Chiozzini C, Nicastri E, Andreoni M, Borduagni O, Sgadari C, Rezza G, Stürzl M, ... Ensoli B, et al. Clearance of Human Herpesvirus 8 from Blood and Regression of Leukopenia-Associated Aggressive Classic Kaposi's Sarcoma during Interferon-α Therapy: A Case Report Clinical Infectious Diseases. 33: 1782-1785. PMID 11641829 DOI: 10.1086/323982 |
0.595 |
|
| 2001 |
Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, Palladino C, Zietz C, Leone P, Stürzl M, Buttò S, Cafaro A, Monini P, Ensoli B. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 tat protein and basic fibroblast growth factor Molecular Biology of the Cell. 12: 2934-2946. PMID 11598182 DOI: 10.1091/Mbc.12.10.2934 |
0.646 |
|
| 2001 |
Guenzi E, Töpolt K, Cornali E, Lubeseder‐Martellato C, Jörg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, et al. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. The Embo Journal. 20: 5568-5577. PMID 11598000 DOI: 10.1093/Emboj/20.20.5568 |
0.567 |
|
| 2001 |
Schatz O, Monini P, Bugarini R, Neipel F, Schulz TF, Andreoni M, Erb P, Eggers M, Haas J, Buttò S, Lukwiya M, Bogner JR, Yaguboglu S, Sheldon J, Sarmati L, ... ... Ensoli B, et al. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. Journal of Medical Virology. 65: 123-132. PMID 11505454 DOI: 10.1002/Jmv.2011 |
0.604 |
|
| 2001 |
Ascherl G, Sgadari C, Bugarini R, Bogner J, Schatz O, Ensoli B, Stürzl M. Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability. Aids Research and Human Retroviruses. 17: 1035-9. PMID 11485620 DOI: 10.1089/088922201300343717 |
0.401 |
|
| 2001 |
Rimessi P, Bonaccorsi A, Stürzl M, Fabris M, Brocca-Cofano E, Caputo A, Melucci-Vigo G, Falchi M, Cafaro A, Cassai E, Ensoli B, Monini P. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. Journal of Virology. 75: 7161-7174. PMID 11435597 DOI: 10.1128/Jvi.75.15.7161-7174.2001 |
0.598 |
|
| 2001 |
Ensoli B, Stürzl M, Monini P. Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Advances in Cancer Research. 81: 161-200. PMID 11430595 DOI: 10.1016/S0065-230X(01)81005-8 |
0.657 |
|
| 2001 |
Stürzl M, Zietz C, Monini P, Ensoli B. Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. Advances in Cancer Research. 81: 125-159. PMID 11430594 DOI: 10.1016/S0065-230X(01)81004-6 |
0.64 |
|
| 2001 |
Ensoli B, Sgadari C, Barillari G, Sirianni MC, Stürzl M, Monini P. Biology of Kaposi's sarcoma. European Journal of Cancer. 37: 1251-1269. PMID 11423257 DOI: 10.1016/S0959-8049(01)00121-6 |
0.677 |
|
| 2001 |
Barre-Sinoussi F, Berkley S, Bhamarapravati N, Birx D, Bloom B, Carvalheiro J, Ganguly N, Johnston M, Kazatchkine M, Makgoba WM, Monico SM, Nathanson N, Schild G, Wigzell H, Yamasaki S, ... ... Ensoli B, et al. Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1 Aids. 15: W1-W25. PMID 11371709 DOI: 10.1097/00002030-200104130-00030 |
0.357 |
|
| 2001 |
Betti M, Voltan R, Marchisio M, Mantovani I, Boarini C, Nappi F, Ensoli B, Caputo A. Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application. Vaccine. 19: 3408-19. PMID 11348705 DOI: 10.1016/S0264-410X(01)00067-6 |
0.36 |
|
| 2001 |
Bussolino F, Mitola S, Serini G, Barillari G, Ensoli B. Interactions between endothelial cells and HIV-1. The International Journal of Biochemistry & Cell Biology. 33: 371-90. PMID 11312107 DOI: 10.1016/S1357-2725(01)00024-3 |
0.437 |
|
| 2001 |
Cafaro A, Titti F, Fracasso C, Maggiorella MT, Baroncelli S, Caputo A, Goletti D, Borsetti A, Pace M, Fanales-Belasio E, Ridolfi B, Negri DR, Sernicola L, Belli R, Corrias F, ... ... Ensoli B, et al. Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine. 19: 2862-77. PMID 11282197 DOI: 10.1016/S0264-410X(01)00002-0 |
0.328 |
|
| 2000 |
Ensoli B, Stürzl M, Monini P. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Seminars in Cancer Biology. 10: 367-381. PMID 11100885 DOI: 10.1006/Scbi.2000.0329 |
0.686 |
|
| 2000 |
Cafaro A, Caputo A, Maggiorella MT, Baroncelli S, Fracasso C, Pace M, Borsetti A, Sernicola L, Negri DR, Ten Haaft P, Betti M, Michelini Z, Macchia I, Fanales-Belasio E, Belli R, ... ... Ensoli B, et al. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. Journal of Medical Primatology. 29: 193-208. PMID 11085582 DOI: 10.1034/j.1600-0684.2000.290313.x |
0.357 |
|
| 2000 |
Tinari A, Monini P, Marchetti M, Ammendolia MG, Leone P, Ensoli B, Superti F. Lytic growth of human herpesvirus 8: morphological aspects. Ultrastructural Pathology. 24: 301-310. PMID 11071568 DOI: 10.1080/019131200750035021 |
0.601 |
|
| 2000 |
Rezza G, Dorrucci M, Serraino D, Andreoni M, Giuliani M, Zerboni R, Sarmati L, Colangeli V, Salassa B, Monini P, Ensoli B, Pezzotti P. Incidence of Kaposi's sarcoma and HHV-8 seroprevalence among homosexual men with known dates of HIV seroconversion Aids. 14: 1647-1653. PMID 10983652 DOI: 10.1097/00002030-200007280-00021 |
0.624 |
|
| 2000 |
Borsetti A, Parolin C, Ridolfi B, Sernicola L, Geraci A, Ensoli B, Titti F. CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses. Journal of Virology. 74: 6689-94. PMID 10864687 DOI: 10.1128/JVI.74.14.6689-6694.2000 |
0.364 |
|
| 2000 |
Sgadari C, Toschi E, Palladino C, Barillari G, Carlei D, Cereseto A, Ciccolella C, Yarchoan R, Monini P, Stürzl M, Ensoli B. Mechanism of paclitaxel activity in Kaposi's sarcoma Journal of Immunology. 165: 509-517. PMID 10861090 DOI: 10.4049/Jimmunol.165.1.509 |
0.616 |
|
| 2000 |
Rezza G, Tchangmena OB, Andreoni M, Bugarini R, Toma L, Bakary DK, Glikoutou M, Sarmati L, Monini P, Pezzotti P, Ensoli B. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sexually Transmitted Diseases. 27: 159-164. PMID 10726650 DOI: 10.1097/00007435-200003000-00008 |
0.561 |
|
| 2000 |
Rezza G, Dorrucci M, Andreoni M, Arpino C, De Luca A, Monini P, Nicastri E, Alliegro MB, Pezzotti P, Ensoli B. Does HHV-8 have a protective role on the development of HIV encephalopathy? Italian HIV-Seroconversion Study. Neurology. 53: 2032-6. PMID 10599777 DOI: 10.1212/WNL.53.9.2032 |
0.675 |
|
| 2000 |
Annunziato F, Galli G, Nappi F, Cosmi L, Manetti R, Maggi E, Ensoli B, Romagnani S. Limited expression of R5-tropic HIV-1 in CCR5-positive type 1–polarized T cells explained by their ability to produce RANTES, MIP-1α, and MIP-1β Blood. 95: 1167-1174. DOI: 10.1182/BLOOD.V95.4.1167.004K11_1167_1174 |
0.339 |
|
| 1999 |
Rezza G, Dorrucci M, Andreoni M, Arpino C, Luca AD, Monini P, Nicastri E, Alliegro MB, Pezzotti P, Ensoli B. Does HHV-8 have a protective role on the development of HIV encephalopathy? Neurology. 53: 2032-2032. PMID 10932300 DOI: 10.1212/Wnl.55.3.459-A |
0.687 |
|
| 1999 |
Stürzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B. Expression of K13/v-FLIP Gene of Human Herpesvirus 8 and Apoptosis in Kaposi's Sarcoma Spindle Cells Journal of the National Cancer Institute. 91: 1725-1733. PMID 10528022 DOI: 10.1093/Jnci/91.20.1725 |
0.585 |
|
| 1999 |
Ascherl G, Hohenadl C, Monini P, Zietz C, Browning PJ, Ensoli B, Stürzl M. Expression of human herpesvirus-8 (HHV-8) encoded pathogenic genes in Kaposi's sarcoma (KS) primary lesions. Advances in Enzyme Regulation. 39: 331-339. PMID 10470382 DOI: 10.1016/S0065-2571(98)00019-3 |
0.602 |
|
| 1999 |
Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Zerboni R, Salassa B, Colangeli V, Sarmati L, Nicastri E, Barbanera M, Pristerà R, Aiuti F, Ortona L, Ensoli B. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. Journal of the National Cancer Institute. 91: 1468-1474. PMID 10469747 DOI: 10.1093/Jnci/91.17.1468 |
0.688 |
|
| 1999 |
Cafaro A, Caputo A, Fracasso C, Maggiorella MT, Goletti D, Baroncelli S, Pace M, Sernicola L, Koanga-Mogtomo ML, Betti M, Borsetti A, Belli R, Akerblom L, Corrias F, Buttò S, ... ... Ensoli B, et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nature Medicine. 5: 643-50. PMID 10371502 DOI: 10.1038/9488 |
0.394 |
|
| 1999 |
Monini P, Colombini S, Stürzl M, Goletti D, Cafaro A, Sgadari C, Buttò S, Franco M, Leone P, Fais S, Leone P, Melucci-Vigo G, Chiozzini C, Carlini F, Ascherl G, ... ... Ensoli B, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood. 93: 4044-58. PMID 10361101 DOI: 10.1182/Blood.V93.12.4044.412K39_4044_4058 |
0.617 |
|
| 1999 |
Stürzl M, Wunderlich A, Ascherl G, Hohenadl C, Monini P, Zietz C, Browning P, Neipel F, Biberfeld P, Ensoli B. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia. 13. PMID 10232382 DOI: 10.1038/Sj.Leu.2401323 |
0.54 |
|
| 1999 |
Monini P, Carlini F, Stürzl M, Rimessi P, Superti F, Franco M, Melucci-Vigo G, Cafaro A, Goletti D, Sgadari C, Butto S, Leone P, Leone P, Chiozzini C, Barresi C, ... ... Ensoli B, et al. Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) Reactivation in Primary Effusion Lymphoma Cells and Reduces HHV-8 Load in Cultured Peripheral Blood Mononuclear Cells Journal of Virology. 73: 4029-4041. PMID 10196299 DOI: 10.1128/Jvi.73.5.4029-4041.1999 |
0.593 |
|
| 1999 |
Ensoli B, Sirianni MC. Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology. Critical Reviews in Oncogenesis. 9: 107-24. PMID 9973245 DOI: 10.1615/CRITREVONCOG.V9.I2.20 |
0.347 |
|
| 1999 |
Ascherl G, Hohenadl C, Schatz O, Shumay E, Bogner J, Eckhart L, Tschachler E, Monini P, Ensoli B, Stürzl M. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy. Blood. 93: 4232-4241. DOI: 10.1182/Blood.V93.12.4232 |
0.692 |
|
| 1999 |
Monini P, Carlini F, Stürzl M, Superti F, Franco M, Melucci-Vigo G, Cafaro A, Goletti D, Sgadari C, Buttò S, Leone P, Leone P, Chiozzini C, Barresi C, Tinari A, ... ... Ensoli B, et al. α-Interferon inhibits HHV-8 reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured PBMC Journal of Acquired Immune Deficiency Syndromes. 21. DOI: 10.1097/00126334-199905010-00071 |
0.54 |
|
| 1999 |
Colombini S, Monini P, Stürzl M, Goletti D, Cafaro A, Sgadari C, Buttò S, Franco M, Leone P, Leone P, Melucci-Vigo G, Ascherl G, Ramazzotti E, Andreoni M, Rezza G, ... ... Ensoli B, et al. Reactivation of HHV-8 infection by inflammatory cytokines (IC) increased in patients with Kaposi's sarcoma (KS). Journal of Acquired Immune Deficiency Syndromes. 21. DOI: 10.1097/00126334-199905010-00065 |
0.568 |
|
| 1999 |
Goletti D, Monini P, Colombini S, Leone P, Cafaro A, Stürzl M, Franco M, Leone P, Ensoli B. Expanded tropism of Human Herpesvirus-8 (HHV-8) for hematopoietic-derived cells upon Kaposi's sarcoma (KS) development Journal of Acquired Immune Deficiency Syndromes. 21. DOI: 10.1097/00126334-199905010-00064 |
0.572 |
|
| 1999 |
Ascherl G, Hohenadl C, Schatz O, Bogner J, Eckhart J, Tschachler E, Monini P, Ensoli B, Stürzl M. Detection Of Increased Vegf Serum Concentrations In Hiv-1-Infected Patients: Implications For Aids-Associated Vasculopathy Journal of Acquired Immune Deficiency Syndromes. 21. DOI: 10.1097/00126334-199905010-00061 |
0.657 |
|
| 1999 |
Barillari G, Sgadari C, Gendelman R, Morris CB, Palladino C, Nair BC, Markham P, Sturzl M, Ensoli B. The HIV-1 Tat protein promotes angiogenesis and Kaposi's sarcoma development by engaging RGD-binding integrins. Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A19. DOI: 10.1097/00126334-199905010-00060 |
0.341 |
|
| 1999 |
Toschi E, Barillari G, Sgadari C, Palladino C, Cristofaro A, Ciccolella C, Stürzl M, Ensoli B. The HIV-1 Tat protein cooperates with basic fibroblast growth factor in inducing vascular permeability and edema: implications for AIDS-associated Kaposi's sarcoma (KS) pathogenesis Jaids: Journal of Acquired Immune Deficiency Syndromes. 21: A19. DOI: 10.1097/00126334-199905010-00059 |
0.344 |
|
| 1999 |
Rezza G, Andreoni M, Dorrucci M, Pezzotti P, Monini P, Ensoli B. Risk of KS and other AIDS defining diseases in HIV-HHV-8 coinfected individuals. Journal of Acquired Immune Deficiency Syndromes. 21. DOI: 10.1097/00126334-199905010-00023 |
0.643 |
|
| 1998 |
Kelly GD, Ensoli B, Gunthel CJ, Offermann MK. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells Aids. 12: 1753-1761. PMID 9792375 DOI: 10.1097/00002030-199814000-00006 |
0.322 |
|
| 1998 |
Rezza G, Lennette ET, Giuliani M, Pezzotti P, Caprilli F, Monini P, Buttò S, Lodi G, Di Carlo A, Levy JA, Ensoli B. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. International Journal of Cancer. Journal International Du Cancer. 77: 361-5. PMID 9663596 DOI: 10.1002/(Sici)1097-0215(19980729)77:3<361::Aid-Ijc9>3.0.Co;2-M |
0.629 |
|
| 1998 |
Fiorelli V, Gendelman R, Sirianni MC, Chang HK, Colombini S, Markham PD, Monini P, Sonnabend J, Pintus A, Gallo RC, Ensoli B. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 91: 956-67. PMID 9446657 DOI: 10.1182/Blood.V91.3.956.956_956_967 |
0.634 |
|
| 1998 |
Monini P, Colombini S, Goletti D, Stürzl M, Cafaro A, Franco M, Sgadari C, Leone P, Carlini F, Ensoli B. Interaction Between Inflammatory Cytokines And Hhv-8 Infected Monocytes Are Key To The Development Of Kaposi'S Sarcoma (Ks) Journal of Acquired Immune Deficiency Syndromes. 17. DOI: 10.1097/00042560-199804010-00081 |
0.573 |
|
| 1998 |
Monini P, Franco M, Carlini F, Goletti D, Cafaro A, Sgadari C, Leone P, Superti F, Rezza G, Andreoni M, Sturzl M, Ensoli B. αIFN AND HIV-1 PROTEASE INHIBITORS (PI) INHIBIT HHV-8 INFECTION: POSSIBLE THERAPEUTIC APPROACHES FOR KAPOSI'S SARCOMA (KS) Journal of Acquired Immune Deficiency Syndromes. 17. DOI: 10.1097/00042560-199804010-00040 |
0.671 |
|
| 1997 |
Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. Aids (London, England). 11: 1421-31. PMID 9342064 DOI: 10.1097/00002030-199712000-00006 |
0.306 |
|
| 1997 |
Fiorelli V, Sirianni C, Gendelman R, Colombini S, Stürzl M, Monini P, Cafaro A, Butto S, Leonc P, Gallo RC, Ensoli B. Th-1 cytokine profile in PBMC and tumor infiltrating lymphocytes (TIL) of HHV-8+ Kaposi's sarcoma (KS) patients: role of γIFN in KS development (an immune response to HHV-8 ?) Journal of Acquired Immune Deficiency Syndromes. 14. DOI: 10.1097/00042560-199704010-00111 |
0.553 |
|
| 1997 |
Barillari G, Fiorelli V, Gendelman R, Colombini S, Morris CB, Sgadari C, Markham P, Gallo RC, Ensoli B. HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging theαvβ3 integrin: 68 Journal of Acquired Immune Deficiency Syndromes. 14. DOI: 10.1097/00042560-199704010-00109 |
0.339 |
|
| 1997 |
Nair BC, O'Neil T, Chang HC, Ensoli B, Markham P. Soluble Recombinant HIV-1 Tat Shares Features with Heparin-Binding Growth Factors Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14: A27. DOI: 10.1097/00042560-199704010-00087 |
0.302 |
|
| 1997 |
Monini P, Lcllis Ld, Rimcssi P, Grandi P, Franco M, Leonc L, Rosso R, Rossi T, Aiuti F, Ledi GL, Ensoli B, Cassai E. Presence of HHV-8 DNA in semen of inmmunocompetent HIV-negative individuals from different geographical areas in Italy.: 34 Journal of Acquired Immune Deficiency Syndromes. 14. DOI: 10.1097/00042560-199704010-00075 |
0.626 |
|
| 1996 |
Lisziewicz J, Sun D, Gallo RC, Ensoli B, Lori F. Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines. Human Gene Therapy. 7: 2209-16. PMID 8953311 DOI: 10.1089/Hum.1996.7.18-2209 |
0.426 |
|
| 1996 |
Brother MB, Chang HK, Lisziewicz J, Su D, Murty LC, Ensoli B. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys. Virology. 222: 252-6. PMID 8806505 DOI: 10.1006/VIRO.1996.0416 |
0.425 |
|
| 1995 |
Lisziewicz J, Sun D, Trapnell B, Thomson M, Chang HK, Ensoli B, Peng B. An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy. Journal of Virology. 69: 206-12. PMID 7983711 DOI: 10.1128/JVI.69.1.206-212.1995 |
0.432 |
|
| 1995 |
Buonaguro L, Buonaguro FM, Tornesello ML, Beth-Giraldo E, Del Gaudio E, Ensoli B, Giraldo G. Role of HIV-1 Tat in the pathogenesis of AIDS-associated Kaposi's sarcoma. Antibiotics and Chemotherapy. 46: 62-72. PMID 7826041 DOI: 10.1159/000423634 |
0.372 |
|
| 1995 |
Ensoli F, Cafaro A, Fiorelli V, Vannelli B, Ensoli B, Thiele CJ. HIV-1 infection of primary human neuroblasts. Virology. 210: 221-5. PMID 7793075 DOI: 10.1006/VIRO.1995.1336 |
0.437 |
|
| 1995 |
VandenDriessche T, Chuah MK, Chiang L, Chang HK, Ensoli B, Morgan RA. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes. Journal of Virology. 69: 4045-52. PMID 7769662 DOI: 10.1128/jvi.69.7.4045-4052.1995 |
0.428 |
|
| 1995 |
Chuah MK, VandenDriessche T, Chang HK, Ensoli B, Morgan RA. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR. Human Gene Therapy. 5: 1467-75. PMID 7711139 DOI: 10.1089/HUM.1994.5.12-1467 |
0.428 |
|
| 1995 |
Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proceedings of the National Academy of Sciences of the United States of America. 92: 4838-42. PMID 7539135 DOI: 10.1073/Pnas.92.11.4838 |
0.421 |
|
| 1995 |
Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. The Journal of Clinical Investigation. 95: 1723-34. PMID 7535796 DOI: 10.1172/JCI117849 |
0.39 |
|
| 1994 |
Ensoli F, Ensoli B, Thiele CJ. HIV-1 gene expression and replication in neuronal and glial cell lines with immature phenotype: effects of nerve growth factor. Virology. 200: 668-76. PMID 8178451 DOI: 10.1006/VIRO.1994.1230 |
0.415 |
|
| 1994 |
Ensoli B, Gendelman R, Markham P, Fiorelli V, Colombini S, Raffeld M, Cafaro A, Chang HK, Brady JN, Gallo RC. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 371: 674-80. PMID 7935812 DOI: 10.1038/371674A0 |
0.385 |
|
| 1994 |
Browning PJ, Sechler JMG, Kaplan M, Washington RH, Gendelman R, Yarchoan R, Ensoli B, Gallo RC. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls [see comments] Blood. 84: 2711-2720. DOI: 10.1182/Blood.V84.8.2711.2711 |
0.431 |
|
| 1993 |
Ensoli B, Buonaguro L, Barillari G, Fiorelli V, Gendelman R, Morgan RA, Wingfield P, Gallo RC. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. Journal of Virology. 67: 277-87. PMID 8416373 DOI: 10.1128/Jvi.67.1.277-287.1993 |
0.408 |
|
| 1993 |
Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proceedings of the National Academy of Sciences of the United States of America. 90: 7941-5. PMID 7690138 DOI: 10.1073/Pnas.90.17.7941 |
0.3 |
|
| 1992 |
Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunological Reviews. 127: 147-55. PMID 1506004 DOI: 10.1111/J.1600-065X.1992.Tb01412.X |
0.395 |
|
| 1992 |
Buonaguro L, Barillari G, Chang HK, Bohan CA, Kao V, Morgan R, Gallo RC, Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. Journal of Virology. 66: 7159-67. PMID 1279199 DOI: 10.1128/Jvi.66.12.7159-7167.1992 |
0.349 |
|
| 1991 |
Ensoli B, Barillari G, Gallo RC. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematology/Oncology Clinics of North America. 5: 281-95. PMID 2022594 DOI: 10.1016/S0889-8588(18)30441-6 |
0.392 |
|
| 1991 |
Ensoli B, Barillari G, Buonaguro L, Gallo RC. Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma. Advances in Experimental Medicine and Biology. 303: 27-38. PMID 1805571 DOI: 10.1007/978-1-4684-6000-1_4 |
0.376 |
|
| 1990 |
Lusso P, Di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, Derocco SE, Kalyanaraman VS, Gallo RC. In Reply: Pseudotypes in HIV-Infected Mice. Science (New York, N.Y.). 250: 1153-4. PMID 17840195 DOI: 10.1126/Science.250.4984.1153 |
0.357 |
|
| 1990 |
Lusso P, di Marzo Veronese F, Ensoli B, Franchini G, Jemma C, DeRocco SE, Kalyanaraman VS, Gallo RC. Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science (New York, N.Y.). 247: 848-52. PMID 2305256 DOI: 10.1126/Science.2305256 |
0.422 |
|
| 1990 |
Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345: 84-6. PMID 2184372 DOI: 10.1038/345084A0 |
0.454 |
|
| 1989 |
Lusso P, Ensoli B, Markham PD, Ablashi DV, Salahuddin SZ, Tschachler E, Wong-Staal F, Gallo RC. Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6. Nature. 337: 370-3. PMID 2463490 DOI: 10.1038/337370A0 |
0.426 |
|
| 1989 |
Ensoli B, Lusso P, Schachter F, Josephs S, Rappaport J, Negro F, Gallo R, Wong-Staal F. Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. The Embo Journal. 8: 3019-3027. DOI: 10.1002/j.1460-2075.1989.tb08452.x |
0.439 |
|
| 1988 |
Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, Shaw GM, Hahn BH, Wong-Staal F. Biologically diverse molecular variants within a single HIV-1 isolate Nature. 334: 444-447. PMID 2841608 DOI: 10.1038/334444A0 |
0.431 |
|
| 1987 |
Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science. 237: 888-893. PMID 3497453 DOI: 10.1126/Science.3497453 |
0.347 |
|
| 1987 |
Arya SK, Beaver B, Jagodzinski L, Ensoli B, Kanki PJ, Albert J, Fenyo EM, Biberfeld G, Zagury JF, Laure F. New human and simian HIV-related retroviruses possess functional transactivator (tat) gene Nature. 328: 548-550. PMID 3039372 DOI: 10.1038/328548A0 |
0.373 |
|
| Show low-probability matches. |